MOSUNETUZUMAB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where MOSUNETUZUMAB was used for Product used for unknown indication.
Most Reported Side Effects for MOSUNETUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 96 | 19.0% | 7 | 74 |
| Disease progression | 65 | 12.9% | 17 | 4 |
| Covid-19 | 50 | 9.9% | 8 | 26 |
| Neutropenia | 39 | 7.7% | 4 | 7 |
| Death | 38 | 7.5% | 38 | 2 |
| Covid-19 pneumonia | 37 | 7.3% | 16 | 35 |
| Malignant neoplasm progression | 37 | 7.3% | 26 | 2 |
| Disorientation | 31 | 6.1% | 31 | 0 |
| Neurological symptom | 31 | 6.1% | 31 | 0 |
| Vasogenic cerebral oedema | 31 | 6.1% | 31 | 0 |
| Pneumonia | 30 | 5.9% | 14 | 15 |
| Off label use | 29 | 5.7% | 18 | 2 |
| Diffuse large b-cell lymphoma recurrent | 28 | 5.5% | 28 | 0 |
| Therapy partial responder | 26 | 5.1% | 25 | 0 |
| Pyrexia | 23 | 4.6% | 2 | 12 |
Other Indications for MOSUNETUZUMAB
B-cell lymphoma (158)
Follicular lymphoma (144)
Non-hodgkin's lymphoma (54)
Diffuse large b-cell lymphoma (46)
Diffuse large b-cell lymphoma stage iv (29)
Chronic lymphocytic leukaemia (21)
Non-hodgkin's lymphoma unspecified histology indolent (20)
Follicular lymphoma recurrent (8)
Follicular lymphoma refractory (6)
Non-hodgkin's lymphoma metastatic (6)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)